When it comes to building the ideal patient cohort, the breadth and variety of demographic and clinical criteria available to select from is critical.etc…

The COVID-19 pandemic has worsened the drug overdose epidemic in the United States. The evidence of the intersection of these public health crises has been recently emphasized in…

Today, the multiple disparate touch points required for clinical research are burdensome for patients, sites and sponsors.etc…

What is synthetic data and how can it be used to improve patient outcomes and life sciences? In this discussion moderated by Su Huang,etc…

The past year has illustrated the critical role of real-world data and evidence in clinical trials research and healthcare innovation.etc…

In this conversation moderated by Vera Mucaj, Head of Trials and Chief Scientist at Datavant, our panelists will share how they’re thinking about current trends and future needs…

In this session co-hosted by Datavant and Mirador Analytics, we’ll share:etc…

In this discussion, Datavant and Dr. Michael Kruer of Phoenix Children’s Hospital, Dr. Jacob Kean of the University of Utah, and Paul Gross,,etc…